Collegium Pharmaceutical (COLL) FCF Margin Growth (3y) (2019 - 2026)
Powered by 
Analysis
Collegium Pharmaceutical (COLL) FCF Margin Growth (3y) (2019 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | 1,461.00 |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | -2,596.00 |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | 874.00 |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | 982.00 |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 1,832.00 |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | 1,733.00 |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | - |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | -176.00 |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | 1,592.00 |
| 10 | Collegium Pharmaceutical | 753.09 Mn | 603.77 Mn | 110.29 Mn | -3,809.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -3,809.00 |
| Mar 31, 2026 | 1,038.00 |
| Dec 31, 2025 | 1,307.00 |
| Sep 30, 2025 | 379.00 |
| Jun 30, 2025 | 613.00 |
| Mar 31, 2025 | 6,107.00 |
| Dec 31, 2024 | -8,420.00 |
| Sep 30, 2024 | -2,734.00 |
| Jun 30, 2024 | 1,147.00 |
| Mar 31, 2024 | 1,938.00 |
| Dec 31, 2023 | 2,121.00 |
| Sep 30, 2023 | 1,396.00 |
| Jun 30, 2023 | 1,841.00 |
| Mar 31, 2023 | 2,880.00 |
| Dec 31, 2022 | 2,659.00 |
| Sep 30, 2022 | 2,712.00 |
| Jun 30, 2022 | 1,404.00 |
| Mar 31, 2022 | -1,440.00 |
| Dec 31, 2021 | 7,523.00 |
| Sep 30, 2021 | -3,421.00 |